Actualités

14.03.2024 - andera Life Sciences - Press releases

Andera Partners’ portfolio company Tubulis closes upsized €128 Million Series B2 to accelerate the d…

14.03.2024 - andera Life Sciences - Press releases

Amolyt Pharma, an Andera Partners’ portfolio company, announces its sale to AstraZeneca

21.02.2024 - andera Life Sciences - Press releases

MMI Raises $110 Million in Series C Financing

12.02.2024 - andera Life Sciences - Recruitment

Internship Offer – Andera Life Sciences

14.11.2023 - andera Life Sciences - Press releases

Andera Partners co-leads a €67.5 million ($72 million) oversubscribed Series C round for cancer immu…

27.10.2023 - andera Life Sciences - Press releases

JenaValve Announces Late-Breaking Data from the ALIGN-AR Pivotal Trial Meeting Safety and Efficacy E…

11.10.2023 - andera Life Sciences - Press releases

Agomab Raises $100 Million Series C to Advance Fibrosis-focused Pipeline

05.10.2023 - andera Life Sciences - Press releases

Agomab Receives FDA Fast Track Designation for AGMB-129 in Fibrostenosing Crohn’s Disease and Starts…

24.07.2023 - andera Life Sciences - Press releases

Crescendo Biologics secures $32M and announces expansion of CB307 Phase 1b trial in PSMA+ solid tumo…

27.06.2023 - andera Life Sciences - Press releases

Allecra Therapeutics Submits New Drug Application to the U.S. FDA for EXBLIFEP® for the Treatment of…

01.06.2023 - andera Life Sciences - Press releases

Inotrem announces publication of two key articles on nangibotide Phase II programs in peer-reviewed…

15.05.2023 - andera Life Sciences - Press releases

Andera Partners co-leads a €40 million Series A of Dualyx, a Belgian biotech developing novel Treg t…

20.04.2023 - andera Life Sciences - Press releases

Tubulis Announces Strategic License Agreement with Bristol Myers Squibb to Develop Next Generation A…

18.04.2023 - andera Life Sciences - Press releases

Andera Partners co-leads a Series A extension round of € 47.75 million for radiopharmaceutical compa…

13.04.2023 - andera Life Sciences - Press releases

Andera Partners leads $48.5 Million Series A financing for medical device company BioVentrix®

29.03.2023 - andera Life Sciences - Press releases

Grey Wolf Therapeutics Announces Dosing of First Patient in Phase 1/2 Clinical Study of GRWD5769 in…

15.03.2023 - andera Life Sciences - Press releases

Andera Partners co-leads $25m extension round for FIRE1

03.03.2023 - andera Life Sciences - Press releases

Flamingo Therapeutics and Dynacure Announce Merger to Create Leading RNA Therapeutics Company Focuse…

13.02.2023 - andera Life Sciences - Press releases

Andera Partners Portfolio Company Mineralys Therapeutics Successfully Completes Upsized $192 Million…

02.02.2023 - andera Life Sciences - Press releases

Agomab Reports Positive Phase 1 Results with AGMB-129, a GI-restricted ALK5 Inhibitor for Fibrosteno…

26.01.2023 - andera Life Sciences - Press releases

Andera Partners Participates in the €45 Million Series B Financing of Grey Wolf Therapeutics

10.01.2023 - andera Life Sciences - Press releases

Andera Partners invests in SoniVie, a medtech company developing a promising device for the treatmen…

09.01.2023 - andera Life Sciences - Press releases

Andera Partners participates in the $138 Million Series C Financing of Amolyt Pharma

20.10.2022 - andera Life Sciences - Press releases

T-knife Therapeutics Announces Dosing of First Patient with TK-8001 in the IMAG1NE Phase 1/2 Clinica…

10.10.2022 - andera Life Sciences - Press releases

Andera Partners raises its largest life sciences fund at €456M, demonstrating the attractiveness of…

03.10.2022 - andera Life Sciences - Press releases

Alexion, AstraZeneca Rare Disease to Acquire LogicBio® Therapeutics to Accelerate Growth in Genomic…

16.09.2022 - andera Life Sciences - Press releases

JenaValve Completes Enrollment in the ALIGN-ARIDE Clinical Trial

15.09.2022 - andera Life Sciences - Press releases

TRiCares Raises €47m in a First Closing of its Series C

12.09.2022 - andera Life Sciences - Press releases

Agomab Therapeutics Selected as One of Fierce Biotech’s “Fierce 15” Companies of 2…

20.07.2022 - andera Life Sciences - Press releases

Medical Microinstruments Secures $75M to Advance Robotic Microsurgery

13.07.2022 - andera Life Sciences - Press releases

Agomab Raises Additional $40.5 Million Through Series B Extension Bringing Total Amount to $114M

07.07.2022 - andera Life Sciences - Press releases

Andera Partners strengthens its Life Sciences team with a new partner

13.06.2022 - andera Life Sciences - Press releases

ImCheck Closes Upsized EUR 96 Million (USD 103 Million) Financing to Advance Clinical Validation of…

08.06.2022 - andera Life Sciences - Press releases

Andera Partners co-leads $118 Million Oversubscribed Series B Financing of Mineralys Therapeutics to…

17.05.2022 - andera Life Sciences - Press releases

TRiCares Announces Successful Implantation of Minimally Invasive Topaz Tricuspid Heart Valve Replace…

03.05.2022 - andera Life Sciences - Press releases

Andera Partners leads Tubulis’ €60 million Series B financing to advance its development of novel AD…

26.04.2022 - andera Life Sciences - Press releases

Successful first in human implantation of Topaz Tricuspid Heart Valve Replacement System

07.04.2022 - andera Life Sciences - Press releases

Andera Partners to sell its Life Sciences’ portfolio company ReViral to Pfizer

22.03.2022 - andera Life Sciences - Press releases

Evommune Initiates Phase 1 Study to Evaluate Safety of EVO101, an IRAK4 Inhibitor, in Healthy Volunt…

22.02.2022 - andera Life Sciences - Press releases

Andera Partners supports TargED Biopharmaceuticals in €39 million Series A financing to bring ground…

19.01.2022 - andera Life Sciences - Press releases

JenaValve Announces Strategic Investment and Licensing Agreement with Peijia Medical Limited

13.01.2022 - andera Life Sciences - Press releases

Allecra Therapeutics and ADVANZ PHARMA Sign Exclusive License and Supply Agreement for Allecra’s Ant…

10.01.2022 - andera Life Sciences - Press releases

BioNTech and Crescendo Biologics announce global collaboration to develop multi-specific precision i…

22.11.2021 - andera Life Sciences - Press releases

Vifor Pharma to acquire Sanifit to further strengthen late-stage pipeline in nephrology

28.10.2021 - andera Life Sciences - Press releases

Agomab Therapeutics to Acquire Origo Biopharma

26.10.2021 - andera Life Sciences - Press releases

Andera Partners supports Exciva in a Series A to fight Alzheimer’s disease

16.09.2021 - andera Life Sciences - Press releases

Andera Partners leads Amolyt Pharma’s $80 million Series B alongside Sectoral Asset Management

09.09.2021 - andera Life Sciences - Press releases

Andera Partners leads US$ 83 million series A round in Evommune Inc. for the development of transfor…

02.08.2021 - andera Life Sciences - Press releases

T-knife Announces $110 Million Series B Financing to Advance Pipeline of T-cell Receptor Therapies

27.07.2021 - andera Life Sciences - Press releases

Artios Pharma has completed a $153 million series C

05.07.2021 - andera Life Sciences - Press releases

TRiCares announces the successful first in human implantations of “Topaz”

23.06.2021 - andera Life Sciences - Press releases

Poxel announces the approval of Twymeeg

04.05.2021 - andera Life Sciences - Press releases

Life Sciences portfolio company Gamamabs signs an agreement with Exelixis

27.04.2021 - andera Life Sciences - Andera Partners - Press releases

Andera Partners strengthens its presence in the DACH region

07.04.2021 - andera Life Sciences

Artios Pharma announces collaboration with Novartis

02.03.2021 - andera Life Sciences - Press releases

ReViral and LianBio Announce Exclusive Collaboration

10.02.2021 - andera Life Sciences - Press releases

MedLumics closes upsized EUR 18M financing round and appoints new Chairman

13.01.2021 - andera Life Sciences

MMI appoints healthcare industry veteran Mark Toland as CEO

07.01.2021 - andera Life Sciences - Press releases

AM-Pharma Announces Enrollment and Financing of COVID-19 Cohort in Phase III REVIVAL Trial

05.01.2021 - andera Life Sciences - Press releases

Andera sells its Life Sciences’ portfolio company Arvelle Therapeutics

04.01.2021 - andera Life Sciences - Press releases

Inotrem’s COVID-19 Phase IIa Clinical Trial declared “National Priority Research” by the French gove…

12.10.2020 - andera Life Sciences - Press releases

Medlumics lands a 14M€ new financing round

28.08.2020 - andera Life Sciences - Press releases

Reviral raises $44 million in Series C financing

06.08.2020 - andera Life Sciences - Press releases

T-knife completes €66m Series A financing

23.07.2020 - andera Life Sciences - Press reviews

COVID-19: assessing nangibotide in mechanically ventilated patients with COVID-19

11.06.2020 - andera Life Sciences - Press releases

BioDiscovery sells Corvidia to Novo Nordisk

06.05.2020 - andera Life Sciences - Press releases

Appointment of Michael H. Carrel as chairman of the Axonics board of directors.

06.05.2020 - andera Life Sciences - Press releases

 Axonics Modulation Technologies reports financial results for the 1st quarter 2020 and provides an…

02.04.2020 - andera Life Sciences - Press releases

Dynacure Announces €50M ($55M) Series C Financing

01.04.2020 - andera Life Sciences - Press releases

AM-Pharma Increases Funding to €163m for Phase-III Trial of recAP in SA-AKI

28.02.2020 - andera Life Sciences - Press releases

Allecra Therapeutics announces positive top-Line results for phase 3 ALLIUM clinical trial of EXBLIF…

21.11.2019 - andera Life Sciences - Press releases

Inotrem Announces Enrollment of First Patient in its Phase IIb Trial in the Treatment of Septic Shoc…

11.10.2019 - andera Life Sciences - Press releases

BioDiscovery invests in AgomAb Therapeutics

16.07.2019 - andera Life Sciences - Press releases

BioDiscovery co-leads $133 million Financing in AM-Pharma B.V.

14.02.2019 - andera Life Sciences - Press releases

A syndicate of international investors finance Arvelle Therapeutics

11.02.2019 - andera Life Sciences - Press releases

Grey Wolf Therapeutics completes £10 million series A financing with Andera Partners and Canaan

05.11.2018 - andera Life Sciences - Press releases

Crescendo Biologics announces early licensing by Takeda

05.11.2018 - andera Life Sciences - Press releases

Promising results for the lead program of Genkyotex (BioDiscovery 3) in a fibrotic orphan disease

02.08.2018 - andera Life Sciences - Press releases

Artios Pharma Announces $86 million (£65 million) Series B Financing

06.07.2018 - andera Life Sciences - Press releases

BioDiscovery invests in Dynacure to advance lead program into clinical development

04.06.2018 - andera Life Sciences - Press releases

ENYO Pharma raises €40 million in Series B fundraising

04.06.2018 - andera Life Sciences - Press releases

TRiCares Closes €22 Million ($25.4 Million) Series B Financing Round to Fund Development of Minimall…

22.05.2018 - andera Life Sciences - Press releases

GamaMabs Pharma to present at 2018 ASCO annual meeting results from the First-In-Human clinical stud…

02.05.2018 - andera Life Sciences - Press releases

Crescendo Biologics Ltd. raises $70 Million (€57 Million) in Series B financing

25.04.2018 - andera Life Sciences - Press releases

Corvidia Therapeutics Secures $60 Million in Series B Funding